As R&D investment continues, next-generation GLP-1 products will reinforce the classs role as a transformative force in the treatment of metabolic diseases, including diabetes, obesity and related conditions
Sermorelin is sometimes marketed for weight loss, but strong clinical studies have not shown meaningful benefits for obesity, visceral fat reduction, or GLP-1-related muscle preservation
Dont let saggy skin ruin your weight loss experience
According to clinical trial data for orforglipron, participants achieved an average reduction in body weight of 14.7% over 72 weeks
As a result, people on these medications eat much less
Go over all your medications with a healthcare professional, including OTCs, herbal supplements, and vitamins